MedTrace Logo

Is Cerazette Use Before Nexplanon Insertion Predictive for Bleeding Pattern?

NCT01438736 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 90

Last updated 2011-09-22

No results posted yet for this study

Summary

The purpose of the study is to examine how well three months preceding use of Cerazette progestin only pill predicts the bleeding pattern during following Nexplanon implant use.

Conditions

Interventions

DRUG

Desogestrel 75 micrograms POP (Cerazette), Etonogestrel 68 mg implant (Nexplanon)

Desogestrel 75 micrograms POP daily for 3 monts, followed by etonogestrel 68 mg subdermal implant for following 6 months

DRUG

Etonogestrel 68 mg subdermal implant

Etonogestrel 68 mg subdermal implant for 6 months

Sponsors & Collaborators

Principal Investigators

  • Dan Apter, Docent · VL-Medi Oy

Study Design

Allocation
RANDOMIZED
Purpose
DIAGNOSTIC
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
40 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2011-09-30
Primary Completion
2012-11-30

Countries

  • Finland

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01438736 on ClinicalTrials.gov